The Harvard Medical School Family Health Guide
Diseases Banner
Harvard Health Publications
Order the Book
Contact Us

Sign up for our free e-mail newsletter, HEALTHbeat.  
Email Address:
 
First Name (optional):
 
 
Special Health Information Reports
Incontinence
Weight Loss
Prostate Disease
Vitamins and Minerals
Aching Hands
See All Titles
Browse Health Information
Common Medical Conditions
Wellness & Prevention
Emotional Well Being & Mental Health
Women’s Health
Men’s Health
Heart & Circulatory Health
About the Book
New Information
About the Team
Order the Book
Return to the Family Health Guide Home Page
  Harvard Health Publications
contact us

September 2000


Pregnancy and the Risk of Blood Clots

Of all the complications that may occur during pregnancy, clots that obstruct blood vessels are the leading cause of death in pregnant women. Still, such occurrences are relatively uncommon. How do you know if venous thrombosis, as the condition is called, is something that you should worry about? How do you know if drug treatment is necessary? Researchers are trying to answer these questions.

In Germany, physicians conducted a study to determine the risk of clots associated with certain genetic and protein factors in pregnant women. The researchers collected and analyzed blood samples from women with a history of blood clots during or after pregnancy. These samples were compared to blood samples from women who did not experience these problems. According to the results, women with normal genetic and protein factors had only a 0.03% risk of formation of blood clots. The findings also showed that two genetic abnormalities, known as G20210A prothrombin-gene mutation and factor V Leiden, are individual risk factors for blood clots, increasing the risk of blood clots to 0.5% and 0.25%, respectively. In addition, a woman who has both variations has a greater probability of experiencing blood clots during pregnancy (4.6%). However, only 9.3% of the women with a history of blood clots had both genetic variations. Women with deficiencies in proteins that prevent blood clotting were also at increased risk for this complication during pregnancy (0.4% probability).

The results do not suggest that every pregnant woman should be screened for the genetic variations associated with blood clots. Rather, women who have a personal or family history of problems due to blood clots should discuss the need for screening with their obstetrician. Treatment is available to help prevent the formation of blood clots in women who are at an increased risk.

Back to Top



©2000–2006 President & Fellows of Harvard College